dka pathphysiologymanagement2014-copy-140202235658-phpapp02
DESCRIPTION
so nice ppt fo DKA managementTRANSCRIPT
![Page 1: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/1.jpg)
DIABETIC KETOACIDOSISIN ICU
PRESENTED BY:
DR. ZEENAT YASMEEN ICU RESIDENT
![Page 2: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/2.jpg)
Diabetic Ketoacidosis (DKA)
• A state of absolute or relative insulin deficiency aggravated and followed by
• hyperglycemia, dehydration, and acidosis-producing derangements in metabolism, including production of serum acetone.
• Can occur in both Type I Diabetes and Type II Diabetes In type II diabetics with insulin deficiency/dependence
• It is the presenting symptom for ~ 25% of Type I Diabetics.
![Page 3: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/3.jpg)
Hyperglycemia
Ketosis
Acidosis
*
Definition of Diabetic Ketoacidosis*
3
![Page 4: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/4.jpg)
Pathogenesis of DKA
InsulinDeficiency
Beta-cellfailure
D/CInsulin
Glucotoxicity
![Page 5: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/5.jpg)
Insulindeficiency
IncreasedglucagonGHcortisolcatecholamines
Pathogenesis of DKA
![Page 6: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/6.jpg)
Carbohydrate Metabolism in DKA
Relative or absolute insulin deficiency
glucose output
glycogenolysis
liver
glucose uptake
muscle
![Page 7: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/7.jpg)
Increased Glucose Production in DKA
Gluconeogenesis Glucose
Protein breakdownLipolysis
Glycerol Amino acids Lactate
TG
Activity of gluconeogenicenzymes (PEPCK, PC, PFK)
![Page 8: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/8.jpg)
Increased Production of Ketones in DKA
Lipolysis
FFA Glycerol
Ketogenesis
B-OH-BAcetoacetate
TG
![Page 9: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/9.jpg)
Pathogenesis of DKA
Liver
Increasedglucose
production
Decreasedglucoseuptake
Peripheraltissue
HYPERGLYCEMIA
Increasedrelease
FFA
Increasedketogenesis
Adiposetissue
Liver
KETOACIDOSIS
Osmotic diuresis
Volume depletion Metabolic acidosis
Decreased alkali reserve
![Page 10: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/10.jpg)
Diagnostic Criteria for DKA
DKA
Mild Moderate Severe
Plasma glucose (mg/dl)pHAnion gap Bicarbonate (mEq/l)Urine ketones*Serum ketones*Effective serum Osmol (mOsm/kg)†Alteration in sensoriaor mental obtundation
>2507.25-7.3 >10 15-18positivepositivevariable
alert
>2507.0-<7.24 >1210- <15positivepositivevariable
alert/drowsy
>250<7.0 >12<10positivepositivevariable
stupor/coma
![Page 11: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/11.jpg)
Clinical Presentation of DKA
SignHypothermiaTachycardiaTachypneaKussmaul
breathingIleusAcetone breathAltered sensorium
SymptomsPolydipsiaPolyuriaWeaknessWeight lossNausea Vomiting Abdominal pain
The onset of DKA is usually relative short, ranging from hours to a day or two.
![Page 12: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/12.jpg)
Causes of DKA
• Stressful precipitating event that results in increased catecholamines, cortisol, glucagon. Infection (pneumonia, UTI) Alcohol Stroke Myocardial Infarction Pancreatitis Trauma Medications (steroids) Non-compliance with insulin
![Page 13: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/13.jpg)
Initial Clinical Evaluation
• History and physical examination Secure patient’s ABC Mental status Cardiovascular-renal status Source of infection
• Evaluation of volume and hydration status
• Laboratory studies
![Page 14: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/14.jpg)
• Immediate determination of blood glucose by finger stick, and serum ketones (3-BH) by finger stick or urinary ketones.
• Laboratory studies: ABG’s CBC with differential CMP (glucose, electrolytes, bicarbonate, BUN, creatinine) Serum ketones Urinalysis Bacterial cultures* Cardiac enzymes*
Initial Laboratory Studies
* If clinically indicated
![Page 15: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/15.jpg)
Serum Sodium
Hyponatremia is common in patients with DKA
H2O
H2OH2O
Serum glucose
Na+
H2O
Correction of Serum sodium:
Corrected Na+ = [Na+] 1.6 x glucose (mg/dl) – 100
100
![Page 16: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/16.jpg)
Serum Potassium
Admission serum potassium is frequently elevated (due to a shift of K- from the intracellular to the extracellular space)
K+
OsmolalityAcidosis
K+
Insulinregulates Activity
ofNa+/K+ pump
Na+
K-
K+
K+K+
![Page 17: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/17.jpg)
Anion Gap Formula
• Anion gap can be measured as
• AG=[(Na)-(Hco3+CL)]
![Page 18: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/18.jpg)
Fluid Therapy in DKA
Normal saline, 1-2 L over 1-2 h
NS or ½ NS at 250-500 mL/h
Glucose < 250 mg/dl
D5%1/2NS saline
![Page 19: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/19.jpg)
Caution during fluid management
• Fluid should be replace over 12-24hr • patients are generally depleted 3-6lit in
DKA.• Monitor urine output,heart rate,blood
pressure and respiratory status.• CARE must b taken in patient with CCF
and kidney disease.
![Page 20: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/20.jpg)
Blood Glucose monitoring in DKA• Check initial blood glucose q1h.Goal decrease in
blood glucose is 50-75mg/dl/hr• Once stable(3consecutie values decrease in
target range)change blood glucose monitoringq2h.Resume q1h blood glucose monitoring for each change in the insulin infusion rate.
• Add dextrose5% to IV fluid when blood glucose <250mg/dl.
• For DKA goal blood glucose 150-200mg/dl until anion gap close.
![Page 21: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/21.jpg)
Intravenous Insulin Therapy in DKA
I.V. Bolus: 0.1 U/kg
I.V. drip: 0.1 U/kg/h
Glucose < 250 mg/dl and HCO3 > 15 mmol/l, then,
I.V. drip: 0.05 – 0.1 U/kg/h Until c0rrection of anion gap
![Page 22: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/22.jpg)
CHANGING THE INSULIN INFUSION RATE
• Decrease IV insulin by 50%if blood glucose decrease by >100mg/dl/hr in any 1hr period
• Increase insulin drip by 50%/hr if change in blood glucose is <50mg/dl/hr
• When blood glucose decrease to 250mg/dl insulin infusion may need to be decrease 50% to maintain glucose at target levels(150-200mg/dl).
![Page 23: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/23.jpg)
Transition to Subcutaneous Insulin
Patients with DKA should be treated with IV insulin until ketoacidosis is resolved.
Criteria for resolution of DKACriteria for resolution of DKA:: BG BG ≤≤ 200 mg/dL 200 mg/dL Serum bicarbonate level ≥ 18 mEq/LSerum bicarbonate level ≥ 18 mEq/L Venous pH ≥ 7.3 and anion gap closedVenous pH ≥ 7.3 and anion gap closed
![Page 24: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/24.jpg)
WHEN TO STOP IV INSULIN
• Give short acting insulin SC at twice the hourly IV rate(if iv rate 5u/hr give 10u)
• Failure to give SC insulin may result in rebound hyperglycemia and ketosis due to its short acting effect.
• ENSURE pt has a meal and is eating and awake.
![Page 25: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/25.jpg)
Potassium replacement
K+ = > 5.5 mEq/l; no supplemental is required
K+ = 4 - 5 mEq/l; 20 mEq/L of replacement fluid
K+ = 3 - 4 mEq/l; 40 mEq/L of replacement fluid
If admission K+ = <3 mEq/l give 10-20 mEq/h until K+ >3 mEq/l, then add 40 mEq/L to replacement fluid
![Page 26: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/26.jpg)
pH > 7.0 no bicarbonate
pH < 7.0 and bicarbonate < 5 mEq/l 44.6 mEq in 500 ml 0.45% saline over 1 h until pH > 7.0
Bicarbonate administration
![Page 27: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/27.jpg)
Complications of DKA 1-Complications of associated illnesses e.g.
sepsis or MI.2-Adult respiratory distress syndrome. 3-Thromboembolism (elderly). 4-Complications of treatment:
a-Hypokalemia: Which may lead to:
-Cardiac arrhythmias.
-Cardiac arrest.
-Respiratory muscle weakness.
![Page 28: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/28.jpg)
b-Hypoglycemia.
c-Overhydration and acute pulmonary edema: particularly in:
-Treating children with DKA.
-Adults with compromised renal or cardiac function.
-Elderly with incipient CHF.
![Page 29: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/29.jpg)
d-Neurological complications: Cerebral Edema.
-It occurs mostly in children with DKA.
-Very dangerous and increases mortality.
-The risk is related to the severity, duration and rapid correction of DKA.
Mechanism: The brain adapts by producing
intracellular osmoles (idiogenic osmoles) which stabilize the brain cells from shrinking while the DKA was developing. When the hyperosmolarity is rapidly corrected, the brain becomes hypertonic towards the extracellular fluids water flows into the cells cerebral edema
![Page 30: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/30.jpg)
Diabetic Ketoacidosis is a common, serious and expensive complication in patients with type 1 and type 2 diabetes
Prevention of metabolic decompensation through patient education, strict surveillance of glucose homeostasis and aggressive diabetes management might reduce the high morbidity and mortality associated with diabetic ketoacidosis
Summary
![Page 31: Dka pathphysiologymanagement2014-copy-140202235658-phpapp02](https://reader033.vdocuments.us/reader033/viewer/2022052504/554b180db4c90569098b4e68/html5/thumbnails/31.jpg)
THANK YOU